UC San Diego FIRST Program

加州大学圣地亚哥分校 FIRST 项目

基本信息

  • 批准号:
    10701801
  • 负责人:
  • 金额:
    $ 22.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-09 至 2027-08-31
  • 项目状态:
    未结题

项目摘要

Abstract A diverse biomedical workforce is critical for enhancing scientific innovation, health equity, and inclusive excellence. However, the number of historically underrepresented racial/ethnic (UR) scientists and women, especially UR women remain disproportionately low in the biomedical workforce, particularly as faculty at research institutions. UR and women biomedical researchers are also less likely to be awarded NIH funding and are underrepresented in leadership positions. Key barriers to faculty retention and success include a lack of clarity regarding promotion criteria, effective mentorship and formal structured faculty development programs. In addition, the gap in representation is caused in large part by institutional cultures that lack critical elements of inclusion and equity. Thus, multiple evidence-based strategies are needed to enhance faculty diversity, success and inclusion. Cluster hiring at academic institutions is an effective strategy for enhancing faculty diversity. Formal structured faculty mentorship, research and career development programs improve faculty competencies and success and can impact organizational culture. The goal of the University of California San Diego (UCSD) Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Faculty Development Core is to use evidence-based strategies to enhance FIRST participants’ academic advancement, research success, and inclusive institutional excellence. The objective of the Faculty Development Core is to develop institutional strategies to establish effective mentorship, enhance research and career development and promote interventions that will reduce isolation and increase community building for all UCSD FIRST participants. We hypothesize that UCSD FIRST cohort participants engaging in the Faculty Development Core program components will obtain direction in academic promotion, strong mentorship in research and career development, access to networks of colleagues, integration into their units and inclusion in robust communities of diverse scholars comprised of peers, near-peers and senior faculty across UCSD. We propose three specific aims. Aim 1. Strategy and Methodology. To improve UCSD FIRST faculty training for promotion, tenure and advancement and enhance integration into the department/division and institution. Aim 2. Professional Development and Progression. To improve and support faculty research and career development using evidence-based strategies. Aim 3. Culture and Environment. To reduce isolation, promote community building, support new faculty timely academic advancement and to enhance institutional inclusive excellence. Together, these aims will promote UCSD culture change towards inclusive excellence by using evidence-based strategies to enhance UR faculty academic advancement, research and career development, integration and implementation of system-wide structured faculty development programs to enhance inclusivity.
摘要 多样化的生物医学劳动力对于加强科学创新、健康公平和包容性至关重要。 卓越然而,历史上代表性不足的种族/民族(UR)科学家和妇女的人数, 特别是UR女性在生物医学劳动力中的比例仍然不成比例地低,特别是作为大学的教师, 研究机构UR和女性生物医学研究人员也不太可能获得NIH的资助, 担任领导职务的人数不足。教师保留和成功的关键障碍包括缺乏 明确晋升标准,有效的指导和正式的结构化教师发展计划。在 此外,代表性的差距在很大程度上是由缺乏关键要素的机构文化造成的, 包容和公平。因此,需要多种基于证据的策略来提高教师的多样性, 和包容。学术机构的集群招聘是提高教师多样性的有效策略。 正式结构化的教师指导,研究和职业发展计划提高教师的能力 成功,影响企业文化。加州圣地亚哥大学(UCSD)的目标 教师机构招聘可持续转型(第一)教师发展的核心是使用 以证据为基础的战略,以提高第一参与者的学术进步,研究成功, 具有包容性的优秀机构。教师发展核心的目标是发展机构 建立有效的导师制,加强研究和职业发展, 这些干预措施将减少所有UCSD FIRST参与者的隔离并增加社区建设。我们 假设UCSD FIRST队列参与者参与教师发展核心计划 各组成部分将获得学术晋升方向,研究和职业发展方面的强有力导师, 进入同事网络,融入他们的单位,并融入多样化的强大社区 学者包括同行,近同行和整个UCSD的高级教师。我们提出三个具体目标。目的 1.战略和方法。改善加州大学圣地亚哥分校FIRST教师晋升、终身教职和晋升培训 并加强与部门/部门和机构的融合。目标二。专业发展和 进步。改善和支持教师的研究和职业发展使用循证策略。 目标3.文化与环境。减少孤立,促进社区建设,及时支持新教师 学术进步和提高机构的包容性卓越。这些目标将共同促进 UCSD通过使用基于证据的策略来提高UR教师的包容性卓越文化变革 学术进步、研究和职业发展、整合和实施全系统 结构化的教师发展计划,以提高包容性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VIVIAN REZNIK其他文献

VIVIAN REZNIK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VIVIAN REZNIK', 18)}}的其他基金

Building a Respectful, Inclusive Culture
建立尊重、包容的文化
  • 批准号:
    10652493
  • 财政年份:
    2022
  • 资助金额:
    $ 22.12万
  • 项目类别:
UC San Diego FIRST Program
加州大学圣地亚哥分校 FIRST 项目
  • 批准号:
    10494790
  • 财政年份:
    2022
  • 资助金额:
    $ 22.12万
  • 项目类别:
Building a Respectful, Inclusive Culture
建立尊重、包容的文化
  • 批准号:
    10434593
  • 财政年份:
    2022
  • 资助金额:
    $ 22.12万
  • 项目类别:
UC San Diego RAPID Faculty Development Program in Infectious Diseases
加州大学圣地亚哥分校传染病快速教师发展计划
  • 批准号:
    10677670
  • 财政年份:
    2020
  • 资助金额:
    $ 22.12万
  • 项目类别:
San Diego Leading the Advancement of Underrepresented Neuroscientists for Change (LAUNCH) Program
圣地亚哥领导推动代表性不足的神经科学家变革(LAUNCH)计划
  • 批准号:
    10455485
  • 财政年份:
    2020
  • 资助金额:
    $ 22.12万
  • 项目类别:
UC San Diego RAPID Faculty Development Program in Infectious Diseases
加州大学圣地亚哥分校传染病快速教师发展计划
  • 批准号:
    10065877
  • 财政年份:
    2020
  • 资助金额:
    $ 22.12万
  • 项目类别:
San Diego Leading the Advancement of Underrepresented Neuroscientists for Change (LAUNCH) Program
圣地亚哥领导推动代表性不足的神经科学家变革(LAUNCH)计划
  • 批准号:
    10206279
  • 财政年份:
    2020
  • 资助金额:
    $ 22.12万
  • 项目类别:
San Diego Leading the Advancement of Underrepresented Neuroscientists for Change (LAUNCH) Program
圣地亚哥领导推动代表性不足的神经科学家变革(LAUNCH)计划
  • 批准号:
    10674057
  • 财政年份:
    2020
  • 资助金额:
    $ 22.12万
  • 项目类别:
San Diego Leading the Advancement of Underrepresented Neuroscientists for Change (LAUNCH) Program
圣地亚哥领导“代表性不足的神经科学家促进变革”(LAUNCH)计划
  • 批准号:
    10024515
  • 财政年份:
    2020
  • 资助金额:
    $ 22.12万
  • 项目类别:
UC San Diego RAPID Faculty Development Program in Infectious Diseases
加州大学圣地亚哥分校传染病快速教师发展计划
  • 批准号:
    10456645
  • 财政年份:
    2020
  • 资助金额:
    $ 22.12万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 22.12万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 22.12万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 22.12万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 22.12万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 22.12万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 22.12万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 22.12万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 22.12万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 22.12万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 22.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了